Oral immunization of swine with attenuated Salmonella typhimurium aroA SL3261 expressing a recombinant antigen of Mycoplasma hyopneumoniae (NrDF) primes the immune system for a NrDF specific secretory IgA response in the lungs

Microbial Pathogenesis

Volumn 30, Issue 2, 2001, Pages 101-110

  Fagan, Peter K ^a,b   Walker, Mark J ^a,b   Chin, James ^a,b   Eamens, Graeme J ^a,b   Djordjevic, Steve P ^a,b  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b NSW DEPARTMENT OF PRIMARY INDUSTRIES   (Australia)

Author keywords

AroA; Mycoplasma hyopneumoniae; NrdF; Ribonucleotide reductase; Salmonella typhimurium

Indexed keywords

RECOMBINANT ANTIGEN; RECOMBINANT PROTEIN; RIBONUCLEOTIDE REDUCTASE; SECRETORY IMMUNOGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; LUNG DISEASE; LYMPHOPROLIFERATIVE DISEASE; MYCOPLASMA HYOPNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA TYPHIMURIUM; SWINE; VACCINATION; WEIGHT GAIN;

ANIMALIA; MYCOPLASMA HYOPNEUMONIAE; SALMONELLA TYPHIMURIUM; SUIDAE; SUS SCROFA; TYPHIMURIUM;

EID: 0034967825     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.2000.0412     Document Type: Article

References (53)

1. Molecular characterization of a ribonucleotide reductase (NrdF) gene fragment of Mycoplasma hyopneumoniae and assessment of the recombinant product as an experimental vaccine for enzootic pneumonia
2. Characterization of Mycoplasma suipneumoniae: A mycoplasma causing enzootic pneumonia of pigs
3. Virus pneumonia of pigs: Propagation and characterization of a causative agent
4. Electron microscope observation of the respiratory tract of SPF piglets inoculated with Mycoplasma hyopneumoniae
5. Ciliostasis and loss of cilia induced by Mycoplasma hyopneumoniae in porcine tracheal organ cultures
6. Mycoplasma hyopneumoniae increases the susceptibility of pigs to experimental Pasteurella multocida pneumonia
7. Effect of Mycoplasma hyopneumoniae infection on the development of Haemophilus pleuropneumoniae pneumonia in pigs
8. Development of the early lesions in experimental enzootic pneumoniae of pigs: An ultrastructural and histological study
9. Mycoplasmal diseases
10. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing denatured membrane antigen pool and adjuvant
11. Humoral and cellular immune responses of pigs inoculated with Mycoplasma hyopneumoniae
12. Attempts to demonstrate cell-mediated immune response during Mycoplasma suipneumoniae infection of pigs
13. Mycoplasmal pneumoniae in pigs in Croatia. II. First results of vaccination in controlling the disease
14. Efficacy of vaccination against Mycoplasma hyopneumoniae on infected farms in France
15. Efficacy of Stellamune™ Mycoplasma in European field trials
16. A clinical trial of the vaccine Suvaxyn M. hyo against mycoplasma induced pneumonia (enzootic pneumonia) in pigs. II. Lesions of lungs, pleura and heart (the pluck) of slaughter pigs vaccinated against Mycoplasma hyopneumoniae with Suvaxyn M. hyo
17. A field trial to evaluate a Mycoplasma hyopneumoniae vaccine: Effects on lung lesions and growth rates in swine
18. Study on the efficacy of active immunization against Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae on a large-scale pig farm
19. Aerosol vaccination of pigs against Mycoplasma hyopneumoniae infection
20. Effect of a mycoplasma vaccine on average daily gain in swine
21. Oral immunization of mice and swine with an attenuated Salmonella cholerasuis [Δ cya-12 Δ (crp-CST)19] mutant containing a recombinant plasmid
22. Studies on the pathogenesis of Salmonella typhimurium and Salmonella choleraesuis var kunzendorf infection in weanling pigs
23. Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens
24. Live oral avirulent Salmonella vaccines
25. The molecular basis for the virulence of bacterial pathogens: Implications for oral vaccine development
26. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
27. Immune response of pigs to paternal vaccination with an aromatic-dependent mutant of Salmonella typhimurium
28. Development and duration of protection against salmonellosis in mice and sheep immunized with live aromatic-dependent Salmonella typhimurium
29. Salmonella as carriers of hetrologous antigens
30. Live bacterial vaccines and their application as carriers for foreign antigens
31. Overview of the mucosal immune system
32. New perspectives in vaccine development: Mucosal immunity to infections
33. Oral immunization of mice with attenuated Salmonella typhimurium aroA strains expressing a recombinant Mycoplasma hyopneumoniae antigen (NrdF)
34. Antibody responses in the lungs of mice following oral immunization with Salmonella typhimurium aroA and invasive Escherichia coli strains expressing the filamentous haemagglutinin of Bordetella pertussis
35. Specific lung mucosal and systemic immune responses after oral immunization of mice and Salmonella typhimurium aroA, Salmonella typhi Ty21a and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit
36. Evaluation of an enzyme-linked immunosorbant assay for the detection of Mycoplasma hyopneumoniae antibody in porcine serum
37. Identification and characterization of a Mycoplasma hyopneumoniae adhesin
38. Molecular analysis of a ciliary adhesin gene of Mycoplasma hyopneumoniae strain
39. Comparison of antibody production, lymphocyte stimulation and production induced by four commercial Mycoplasma hyopneumoniae bacterins
40. Swine immunity to an attenuated Salmonella typhimurium mutant containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus
41. From RNA to DNA, why so many reductases?
42. Reduction of ribonucleotides
43. The Bacillus subtilis genes for ribonucleotide reductase are similar to the genes for the second class I NrdE/NrdF enzymes of Enterobacteriaseae
44. The minimal gene complement of Mycoplasma genitalium
45. Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae
46. Comparative analysis of the genomes of the bacteria Mycoplasma genitalium and Mycoplasma pneumoniae
47. Carboxyl-terminal peptides as probes for Escherichia coli ribonucleotide reductase subunit interaction: Kinetic analysis of inhibition studies
48. Inhibition of equine herpes virus type 1 subtype 1-induced ribonucleotide reductase by the nonapeptide YAGAV-VNDL
49. Identification of novel species-specific antigen of Mycoplasma hyopneumoniae by preparative SDS-PAGE ELISA profiling
50. High-copy-number and low-copy-number plasmid vectors for LacZ α-complementation and chloramphenicol or kanamycin-resistance selection
51. Some experiments relating to artificial immunity in enzootic pneumoniae in pigs
52. Western blotting: Electrophoretic transfer of proteins from sodium dodecyl sulfate-poly-acrylamide gels to unmodified nitrocellulose and radiographic detection with antibody an radioiodinated protein
53. Multiple comparisons